OCAT quote: "The company has published unprecedented trial results, has strengthened its balance sheet, has continued to advance its portfolio of intellectual property, has secured management contracts from key scientists and has replaced former management with a new team that is experienced in the development of small biotech companies."
And yet for some reasons with all of the wonderful news above, the stock sits near its yearly low with a MINUS 100 rating from one source, which is the worst possible score.
Do you think perhaps just perhaps there are other VERY IMPORTANT reasons not disclosed in the above quote that are having a serious negative impact on the stock price and/or is it simply a case of the investing world to use an appropriate term being blind to the reality with a stock which is shortly to take off and go on a run this year which will take it easily to $100 a shares as one of the "sages" at another forum predicted(the same guy who came up a little bit short that it would be at $35 by the last day of June of 2015).
It is also interesting that parts of the above quote are 100% different from the SEC filings which paint an entirely different picture, much of which can be interpreted as bleak.
"And now you know the REST of the STORY!"
"For every action, there is an equal and opposite reaction."
